D&O Liability Insurance - C5
D&O Liability Insurance - C5
D&O Liability Insurance - C5
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
DAY 1, TUESDAY, 27 MARCH 2012<br />
8.30 Registration and Coffee<br />
9.00 Conference Co-Chair’s Opening Remarks<br />
Chris Magee, Managing Director,<br />
Hartford Financial Products International Limited<br />
9.15 How to Find Profits in a Challenging D&O<br />
<strong>Insurance</strong> Market: Your Guide to the Next<br />
12 Months<br />
Christoph Leuzinger, Global Deputy Chief Underwriter,<br />
Management <strong>Liability</strong>, Zurich General <strong>Insurance</strong><br />
Geraud Verhille, European Commercial D&O and<br />
Crime Manager, Chartis<br />
Mark Baily, Head of Financial Lines Claims,<br />
Ace European Group<br />
Michael Rieger-Goroncy, International Large Risks<br />
Underwriter, Specialty Lines, Beazley Group<br />
Enrico Nanni, Managing Director, Aon<br />
• What are the macro trends affecting the D&O market<br />
• Where are the main global exposures<br />
• How much D&O capacity is there in the market currently<br />
What changes are expected in the coming 12 months<br />
• What are the main areas of growth Where are insurers<br />
seeing opportunities to get an edge over competitors<br />
- to what extent is there a market for transactional liability<br />
products, given mergers are expected to increase<br />
- where has D&O cover been deemed mandatory<br />
or prescribed as best practice<br />
• What emerging risks must the market factor in<br />
- to what extent are D&Os likely to be targets for losses<br />
stemming from the sovereign debt crisis<br />
- losses caused by rogue traders at banks: what are<br />
shareholders doing by way of taking against officers<br />
responsible<br />
- how has the market reacted to such emerging risks<br />
and what migratory steps are being taken right now<br />
• Pricing trends: are rates reflective of risks<br />
• Overview of recent D&O purchasing: what products are<br />
clients buying and where does Excess cover come in<br />
• How much broader will or should coverage become What<br />
are the implications of ever-broadening of primary coverage<br />
• New products and extensions<br />
• Availability of reinsurance and terms<br />
• Opportunities for profit, loss drivers and D&O insurance<br />
developments in SMEs, large accounts and financial<br />
institutions<br />
- claim trends<br />
- claims from privately held vs listed companies<br />
- pricing developments<br />
- P&L dynamics<br />
- acquisition and transactions costs<br />
- innovation<br />
• What factors are most important to brokers when deciding<br />
which insures to work with<br />
- pricing<br />
- coverage<br />
- ratings<br />
- financial security<br />
- new products capacity<br />
- internal resources, including for claims handling<br />
10.30 Morning Refreshments<br />
10.45 European Sovereign Debt: How Can D&O<br />
Insurers Maintain Profitability During the Crisis<br />
Part 1 – Macroeconomic analysis<br />
Julian Callow, Managing Director/Head of International<br />
Economics and Co-Head of European Economics,<br />
Barclays Capital<br />
• How is the 2008 economic crisis different from the<br />
current situation<br />
• How is economic growth being impaired How are<br />
on-going economic conditions impacting on business<br />
• Who is most significantly impacted by sovereign debt<br />
exposure and what is the wider impact<br />
• To what extent do entities exposed to sovereign debt<br />
also have US exposure<br />
• Outlook for the coming 12-18 months<br />
Part 2 – Impact on D&O insurance<br />
Geraud Verhille, European Commercial D&O<br />
and Crime Manager, Chartis<br />
Nepomuk Loesti, European Financial Institutions<br />
Underwriting, Manager, Chartis<br />
• Impact on the financial institutions D&O<br />
- what were the main insurance implications of the 2008<br />
vs current crisis What is different today<br />
- how does the performance of insurance products in<br />
2008 compare with their current response to economic<br />
conditions<br />
- varying impact for banks, assets managers, insurance<br />
companies and other players<br />
- claims experience so far and potential claims scenarios<br />
• Impact on the commercial companies D&O<br />
- most impacted industry sectors from an insurance<br />
perspective<br />
- recession related claims scenarios and experience<br />
• US exposure for both financial institutions and<br />
commercial products/lines in 2008 vs projected exposures<br />
in the coming months<br />
• Assessing likely impact on insurers’ profitability<br />
12.15 What is the Potential for Claims Arising From<br />
Actions Against D&Os Under Anti-Corruption<br />
Legislation in the UK, US and Beyond<br />
Vivian Robinson QC, Partner, McGuireWoods London<br />
LLP/Formerly General Counsel, the Serious Fraud<br />
Office (SFO),<br />
Suresh Ellawala, Professional & Financial Lines, QBE<br />
• Recent prosecutions and enforcement priorities under<br />
the FCPA<br />
• The UK Bribery Act in practice: early complaints,<br />
investigations and prosecutions<br />
• Understanding the full scope of the law: what offences<br />
by D&Os will qualify for scrutiny under key bribery/anticorruption<br />
legislation and as interpreted by the relevant<br />
authorities<br />
• Ascertaining the full territorial reach of the acts beyond<br />
the US and UK: when will your clients in other<br />
jurisdictions be impacted and how<br />
• 8 out of 10 largest recent FCPA fines are related to UK<br />
or European companies: how is this reflected in D&O<br />
claims<br />
• What provisions should insurers insist on to limit their<br />
own exposures viz. the individual D&Os/the business<br />
entity What questions must insurers ask their insureds<br />
1.00 Networking Lunch<br />
To register call +44 (0) 20 7878 6888 OR fax +44 (0) 20 7878 6885